IDXX — IDEXX Laboratories Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual balance sheet for IDEXX Laboratories, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	PRESS
Standards:	USG	USG	USG	USG	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	144	113	454	288	180
Net Total Accounts Receivable
Net Total Receivables	426	491	530	561	552
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	956	1,101	1,495	1,400	1,414
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	693	768	818	829	747
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	2,437	2,747	3,260	3,293	3,351
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	764	1,236	952	1,068	1,149
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	1,747	2,138	1,775	1,698	1,745
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	690	609	1,485	1,595	1,605
Total Liabilities & Shareholders' Equity	2,437	2,747	3,260	3,293	3,351
Total Common Shares Outstanding